IL166031A0 - New sexual-dysfunction-compound containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof - Google Patents
New sexual-dysfunction-compound containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereofInfo
- Publication number
- IL166031A0 IL166031A0 IL16603104A IL16603104A IL166031A0 IL 166031 A0 IL166031 A0 IL 166031A0 IL 16603104 A IL16603104 A IL 16603104A IL 16603104 A IL16603104 A IL 16603104A IL 166031 A0 IL166031 A0 IL 166031A0
- Authority
- IL
- Israel
- Prior art keywords
- dysfunction
- compound containing
- pharmaceutical formulations
- cocoa powder
- containing rapid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202365A SE0202365D0 (en) | 2002-08-05 | 2002-08-05 | New formulation and use thereof |
PCT/SE2003/001022 WO2004012702A1 (en) | 2002-08-05 | 2003-06-18 | New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL166031A0 true IL166031A0 (en) | 2006-01-15 |
Family
ID=20288677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16603104A IL166031A0 (en) | 2002-08-05 | 2004-12-28 | New sexual-dysfunction-compound containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1539096A1 (en) |
JP (1) | JP2005539008A (en) |
CN (1) | CN1674866B (en) |
AR (1) | AR040797A1 (en) |
AU (1) | AU2003239038B2 (en) |
BR (1) | BR0313224A (en) |
CA (1) | CA2495527C (en) |
IL (1) | IL166031A0 (en) |
MX (1) | MXPA05000978A (en) |
NZ (1) | NZ537520A (en) |
RU (1) | RU2312665C2 (en) |
SE (1) | SE0202365D0 (en) |
TW (1) | TW200418470A (en) |
WO (1) | WO2004012702A1 (en) |
ZA (1) | ZA200500051B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10232113A1 (en) | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
DE102005009241A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with controlled bioavailability |
DE102005009240A1 (en) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with improved pharmacokinetic properties |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
DE102010024866A1 (en) * | 2010-06-24 | 2011-12-29 | Pharmatech Gmbh | Formulation for taste masking |
EP3299010B1 (en) | 2016-09-21 | 2022-11-09 | LTS Lohmann Therapie-Systeme AG | Oral dosage form |
EP3758675A1 (en) | 2018-03-01 | 2021-01-06 | LTS Lohmann Therapie-Systeme AG | Oral dosage form containing theobromine-free cocoa |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755180A (en) * | 1986-06-16 | 1988-07-05 | Alza Corporation | Dosage form comprising solubility regulating member |
FR2717387B1 (en) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Process for the production of chewable tablets based on troxerutin, calcium carbonate, calcium phosphate, arginine aspartate, amoxicillin arginine glutamate. |
US6121276A (en) | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
ES2105970B1 (en) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | ORAL PHARMACEUTICAL COMPOSITION OF CIPROFLOXACINO, NON-AQUEOUS, STABLE AND WITH IMPROVED ORGANOLEPTIC CHARACTERISTICS. |
CA2178021C (en) * | 1996-04-19 | 1999-09-28 | Theodore H. Stanley | Tobacco substitute |
AU715867B2 (en) * | 1997-01-06 | 2000-02-10 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
GT199900061A (en) * | 1998-05-15 | 2000-10-14 | Pfizer | PHARMACEUTICAL FORMULATIONS. |
JP2000095710A (en) * | 1998-09-21 | 2000-04-04 | Taisho Pharmaceut Co Ltd | Oral solid preparation mixed with cacao powder |
JP2000119198A (en) * | 1998-10-16 | 2000-04-25 | Eisai Co Ltd | Phosphodiesterase inhibitor-containing peroral preparation hiding bitterness or the like |
US6060094A (en) * | 1998-10-30 | 2000-05-09 | Nestec S.A. | Method of reducing fat in fat-based coating for confectionery products |
SE9803986D0 (en) | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
SI20109A (en) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stable pharmaceutical formulation |
US6291471B1 (en) | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
EP1246605A2 (en) | 1999-08-10 | 2002-10-09 | The Board Of Regents, The University Of Texas System | Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
JP2001114668A (en) * | 1999-10-13 | 2001-04-24 | Meiji Seika Kaisha Ltd | Chocolate preparation |
WO2001049292A1 (en) | 1999-12-30 | 2001-07-12 | Tap Holdings, Inc. | Oral mucosal dosage forms of apomorphine |
AU2001273545A1 (en) * | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
JP2002193839A (en) * | 2000-12-27 | 2002-07-10 | Meiji Seika Kaisha Ltd | Cocoa pharmaceutical preparation |
CA2435546A1 (en) * | 2001-02-08 | 2002-08-15 | Alice C. Martino | Rapid-onset medicament for the treatment of sexual dysfunction |
US20020172732A1 (en) * | 2001-03-21 | 2002-11-21 | Wies Ter Laak | Composition comprising cocoa |
-
2002
- 2002-08-05 SE SE0202365A patent/SE0202365D0/en unknown
-
2003
- 2003-06-18 AU AU2003239038A patent/AU2003239038B2/en not_active Ceased
- 2003-06-18 NZ NZ537520A patent/NZ537520A/en not_active IP Right Cessation
- 2003-06-18 MX MXPA05000978A patent/MXPA05000978A/en active IP Right Grant
- 2003-06-18 WO PCT/SE2003/001022 patent/WO2004012702A1/en active Application Filing
- 2003-06-18 CN CN038188910A patent/CN1674866B/en not_active Expired - Fee Related
- 2003-06-18 EP EP03733755A patent/EP1539096A1/en not_active Ceased
- 2003-06-18 RU RU2005102835/15A patent/RU2312665C2/en not_active IP Right Cessation
- 2003-06-18 CA CA002495527A patent/CA2495527C/en not_active Expired - Fee Related
- 2003-06-18 JP JP2004525901A patent/JP2005539008A/en active Pending
- 2003-06-18 BR BR0313224-2A patent/BR0313224A/en not_active Application Discontinuation
- 2003-07-25 TW TW092120418A patent/TW200418470A/en unknown
- 2003-08-05 AR AR20030102814A patent/AR040797A1/en not_active Application Discontinuation
-
2004
- 2004-12-28 IL IL16603104A patent/IL166031A0/en unknown
-
2005
- 2005-01-04 ZA ZA2005/00051A patent/ZA200500051B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005539008A (en) | 2005-12-22 |
AU2003239038A1 (en) | 2004-02-23 |
AR040797A1 (en) | 2005-04-20 |
MXPA05000978A (en) | 2005-12-12 |
NZ537520A (en) | 2006-11-30 |
CA2495527C (en) | 2008-12-30 |
WO2004012702A1 (en) | 2004-02-12 |
RU2005102835A (en) | 2005-08-10 |
AU2003239038B2 (en) | 2008-01-03 |
ZA200500051B (en) | 2006-12-27 |
CN1674866A (en) | 2005-09-28 |
RU2312665C2 (en) | 2007-12-20 |
EP1539096A1 (en) | 2005-06-15 |
CN1674866B (en) | 2012-09-26 |
SE0202365D0 (en) | 2002-08-05 |
CA2495527A1 (en) | 2004-02-12 |
BR0313224A (en) | 2005-07-05 |
TW200418470A (en) | 2004-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1400025I1 (en) | Phenethanolamine derivatives and pharmaceutical composition containing them | |
HUP0400384A3 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
HUP0400052A3 (en) | Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
HUP0402236A3 (en) | Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof | |
IL209444A0 (en) | O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them | |
GB0211620D0 (en) | Powder compaction and enrobing | |
EP1487417A4 (en) | Dry powder medicament formulations | |
HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
HK1068555A1 (en) | New formulations and use thereof | |
HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0301713A3 (en) | Pharmaceutical compositions containing propenone derivatives and their use | |
IL159591A0 (en) | Pharmaceutical compositions containing terbinafin and use thereof | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
GB0202900D0 (en) | Novel formulations of drugs | |
HUP0401733A3 (en) | Cyclic amine-derivatives and pharmaceutical compositions containing them | |
IL175746A0 (en) | Oral formulations of desoxypeganine and uses thereof | |
HUP0400023A2 (en) | Novel heterocyclic derivatives and medicinal use thereof and pharmaceutical compositions containing them | |
HUP0303204A3 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing them | |
HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof |